Company patents
Cellino Biotech, Inc.
Cellino Biotech, Inc.'s patent strategy is heavily concentrated in Bioreactors / Cell Culture Apparatus, representing 92.6% of its portfolio, despite a notable decline of -60.0% in 2025 and -25.0% so far in 2026. Surprisingly, the company has also shown significant activity in Image Processing (63.0% of portfolio) and Material & Chemical Analysis (63.0% of portfolio), though both categories have seen substantial declines in patenting activity, with Material & Chemical Analysis and Laboratory Apparatus both experiencing a -100.0% YoY drop so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
27 US filings (since 2023) · 9 categories · 6 themes
Systems and methods for automated monitoring and dynamic adjustment of environmental parameters (e.g., pH, temperature, oxygen, nutrients) and fluid handling within bioreactors to optimize cell/tissue growth or product synthesis.
Devices and systems designed for the cultivation of cells or tissues, often incorporating three-dimensional structures or controlled interfaces to mimic in-vivo environments for biological research or production.
Methods and apparatus specifically tailored for the expansion, differentiation, or genetic modification of cells for therapeutic applications (e.g., CAR T cells, progenitor cells) or for the production of specific biological products (e.g., cultured fat, RNA).
Techniques and apparatus for cultivating cells in three-dimensional structures, including organoids, tissue models, and scaffolds, often involving microfluidics, specialized matrices, or mechanical stimulation to mimic in vivo conditions.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
Development of lipid-based nanoparticles, liposomes, or other molecular platforms to encapsulate and deliver therapeutic agents, particularly nucleic acids, to target tissues or improve pharmacokinetics.
Patents
Showing 1-10 of 35